MSTX, a bio company, has a reverse merger coming up with Savara. The stock plummeted due to noise that it would be delisted...down to $.09 from about $.60. Here we are, with news coming any day now. I have looked into both companies. Savara seems to be an improved pipeline, while MSTX has drugs in Phase 3. Either through the merger, which should be announced this week, or through a drug being passed, this stock has nowhere to go but up. Let me know if anyone has any opposition.
Submitted February 08, 2017 at 01:32PM by ImtheMoneyGuy http://ift.tt/2lp2G9r
No comments:
Post a Comment